TRPX
Therapix Biosciences Ltd.
TRPX
TRPX
Delisted
TRPX was delisted on the 1st of July, 2020.
6 hedge funds and large institutions have $162K invested in Therapix Biosciences Ltd. in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
$120K |
| 2 |
UBS Group
Zurich,
Switzerland
|
$7K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
$34K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TDC
1
Thompson Davis & Co
Richmond,
Virginia
| $120K | +$120K | +28,634 | New |
|
|
2
Morgan Stanley
New York
| $34K | -$7.31K | -1,697 | -18% |
|
|
3
UBS Group
Zurich,
Switzerland
| $7K | +$4.91K | +1,109 | +234% |
|
|
PA
4
Parallel Advisors
San Francisco,
California
| $1K | – | – | – |
|